How effective is selumetinib in treating café-au-lait spots? Can it be completely cleared

Selumetinib is an oral selective MEK inhibitor that mainly works by blocking the RAS/RAF/MEK/ERK signaling pathway. This pathway is abnormally activated in many tumors and genetic diseases, including neurofibromatosis type 1 (NF1)-related lesions. In recent years, selumetinib has received widespread attention in the treatment of NF1 related skin manifestations, especially Café-au-lait spots.

Coffee stain is a type of pigmentation spot on the skin of patients with NF1. It is usually a light brown to dark brown irregular patch that often appears in childhood and persists. Because it is the result of abnormal proliferation and distribution of pigment cells, it has traditionally been difficult to completely remove through surgery or laser means. By inhibiting abnormal signaling pathways, selumetinib aims to reduce lesion progression and improve skin manifestations.

However, clinical practice and research data show that selumetinib has limited therapeutic effect on café-au-lait spots, which is mainly manifested as lighter color and partial area reduction of the plaques, but it is difficult to achieve complete removal. The pigmentation of café-au-lait spots is deep and stable. Although MEK inhibitors can regulate cell signals, they have limited effect on the formed pigmented plaques. Especially for larger and deeper plaques, the therapeutic effect is more limited.

In summary, selumetinib can bring about certain improvements in the treatment of café-au-lait spots, especially in early or lighter pigmented plaques where the pigment may be reduced, but it is difficult to achieve complete removal. Patients should be evaluated by a professional doctor and consider the combination of drug treatment and other skin beauty methods to achieve the best treatment effect and improve the quality of life.

Reference materials:https://www.drugs.com

xa0